findmyKOL

Jennifer Gong

Basic profile

Endocrinology, Diabetes & Metabolism

ORCIDNPI
RegionChicago, IL · MidwestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Jennifer Gong is an Endocrinology/Metabolic physician. OpenAlex indexes 30 publications with 553 citations (h-index 14).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
30publications

Distinct works indexed by OpenAlex, matched via ORCID.

553citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

211 E Chicago Ave
Suite 1050
Chicago, IL 606112637

Telephone

312-944-6677

Registry record last updated 15 Aug 2014.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    75.7%
    RANK Ligand Inhibitor74.1%
    Denosumab100%
    Part B, office-administered73 patients
    Bisphosphonate1.6%
    Zoledronic acid100%
    Part B, office-administered32 patients
  • Metabolism & gastrointestinal

    17.6%
    Insulin Analog5.2%
    Lantus Solostar40%Humalog Kwikpen U-10014%Tresiba Flextouch U-10011%Novolog Flexpen10%Basaglar Kwikpen U-1004%Tresiba Flextouch U-2004%Humalog3%Toujeo Solostar3%Fiasp Flextouch3%Novolog3%Insulin Lispro Kwikpen U-1003%Humalog Kwikpen U-2002%
    Part D<11 patients
    GLP-1 receptor agonist4.6%
    Ozempic64%Trulicity20%Mounjaro13%Victoza 3-Pak3%
    Part D<11 patients

    + 8 more classes in this area

  • Hormonal (systemic)

    4.6%
    l-Thyroxine4.1%
    Levothyroxine Sodium80%Synthroid20%
    Part D91 patients
    Thyroid Hormone Synthesis Inhibitor0.5%
    Methimazole100%
    Part D14 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”